UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis

Journal of drugs in dermatology, 2009-01, Vol.8 (1), p.52

2009

Volltextzugriff (PDF)

A randomized controlled pilot study of strategies to increase adherence in teenagers with acne vulgaris

Journal of the American Academy of Dermatology, 2011-04, Vol.64 (4), p.793-795

2011

Volltextzugriff (PDF)

Sequential Treatment with Triple Combination Cream and Intense Pulsed Light is More Efficacious than Sequential Treatment with an Inactive (Control) Cream and Intense Pulsed Light in Patients with Moderate to Severe Melasma

Dermatologic surgery, 2011-02, Vol.37 (2), p.224-233

2011

Volltextzugriff (PDF)

Safety and Tolerability of a Body Wash and Moisturizer When Applied to Infants and Toddlers with a History of Atopic Dermatitis: Results from an Open-Label Study

Pediatric dermatology, 2012-09, Vol.29 (5), p.590-597

2012

Volltextzugriff (PDF)

Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma

Journal of the American Academy of Dermatology, 2010-06, Vol.62 (6), p.962-967

2010

Volltextzugriff (PDF)

A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% cream

The American journal of dermatopathology, 2009-12, Vol.31 (8), p.794-798

2009

Volltextzugriff (PDF)

Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial

Journal of drugs in dermatology, 2011-08, Vol.10 (8), p.885

2011

Volltextzugriff (PDF)

Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris

Journal of drugs in dermatology, 2008-06, Vol.7 (6 Suppl), p.s18

2008

Volltextzugriff (PDF)

Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis

The Journal of dermatological treatment, 2008-01, Vol.19 (6), p.354-359

2008

Volltextzugriff (PDF)

A multi-center, open-label study to evaluate the safety and efficacy of a sequential treatment regimen of clobetasol propionate 0.05% spray followed by Calcitriol 3 mg/g ointment in the management of plaque psoriasis

Journal of drugs in dermatology, 2011-02, Vol.10 (2), p.158

2011

Volltextzugriff (PDF)

The impact of natural sunlight exposure on the UVB-sun protection factor (UVB-SPF) and UVA protection factor (UVA-PF) of a UVA/UVB SPF 50 sunscreen

Journal of drugs in dermatology, 2011-02, Vol.10 (2), p.150

2011

Volltextzugriff (PDF)

An Open-label, Multicenter Study of the Efficacy and Safety of a Weekday/Weekend Treatment Regimen With Calcitriol Ointment 3 μg/g and Clobetasol Propionate Spray 0.05% in the Management of Plaque Psoriasis

Cutis (New York, N.Y.), 2011-10, Vol.88 (4), p.201-207

2011

Volltextzugriff (PDF)

Is switching retinoids a sound strategy for the treatment of acne vulgaris?

Journal of drugs in dermatology, 2008-06, Vol.7 (6 Suppl), p.s11

2008

Volltextzugriff (PDF)

An Open-Label, Multicenter Study of the Efficacy and Safety of an AM/PM Treatment Regimen With Clobetasol Propionate Spray 0.05% and Calcitriol Ointment 3 μg/g in the Management of Plaque Psoriasis

Cutis (New York, N.Y.), 2011-07, Vol.88 (1), p.46-51

2011

Volltextzugriff (PDF)

The Appearance of Facial Foundation Cosmetics Applied After Metronidazole Gel 1

Cutis (New York, N.Y.), 2011-05, Vol.87 (5), p.251-259

2011

Volltextzugriff (PDF)

Successful Treatment of Moderate to Severe Melasma With Triple-Combination Cream and Glycolic Acid Peels : A Pilot Study

Cutis (New York, N.Y.), 2008-11, Vol.82 (5), p.372-378

2008

Volltextzugriff (PDF)

Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15

Cutis (New York, N.Y.), 2007-04, Vol.79 (4), p.317-321

2007

Volltextzugriff (PDF)

Triple Combination Cream and Glycolic Acid Peels for the Treatment of Moderate to Severe Melasma

Journal of the Dermatology Nurses' Association, 2009-03, Vol.1 (2), p.146-147

2009

Volltextzugriff (PDF)

Clobetasol Propionate 0.05% Spray vs Calcipotriene 0.005%, Betamethasone Dipropionate 0.064% Ointment for the Treatment of Plaque Psoriasis: Results from a Randomized Study

Journal of the Dermatology Nurses' Association, 2009-03, Vol.1 (2), p.145-146

2009

Volltextzugriff (PDF)

The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasis

Cutis (New York, N.Y.), 2007-11, Vol.80 (5 Suppl), p.29

2007

Volltextzugriff (PDF)

The Evolving Role of Topical Treatments in Adjunctive Therapy for Moderate to Severe Plaque Psoriasis: The COBRA Trial: A large-scale community-based trial on moderate and severe psoriasis

Cutis (New York, N.Y.), 2007, Vol.80 (5), p.29-40

2007

Volltextzugriff (PDF)

An open-label, multicenter study of the efficacy and safety of a weekday/weekend treatment regimen with calcitriol ointment 3 microg/g and clobetasol propionate spray 0.05% in the management of plaque psoriasis

Cutis (New York, N.Y.), 2011-10, Vol.88 (4), p.201-207

2011

Volltextzugriff (PDF)

An open-label, multicenter study of the efficacy and safety of an AM/PM treatment regimen with clobetasol propionate spray 0.05% and calcitriol ointment 3 microg/g in the management of plaque psoriasis

Cutis (New York, N.Y.), 2011-07, Vol.88 (1), p.46-51

2011

Volltextzugriff (PDF)

Morphology control of metal-modified zirconium phosphate support structures for the oxygen evolution reaction

Dalton transactions : an international journal of inorganic chemistry, 2020-03, Vol.49 (12), p.3892-39

2020

Volltextzugriff (PDF)

Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

Clinical cancer research, 2022-12, Vol.28 (24), p.5317-5329

2022

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(44)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(23)
Science & Technology
(22)
Life Sciences & Biomedicine
(21)
Female
(19)
Dermatology
(18)
Male
(18)
Adult
(15)
Biological And Medical Sciences
(12)
Middle Aged
(12)
Medical Sciences
(11)
Treatment Outcome
(10)
Dermatologic Agents - Administration & Dosage
(9)
Adolescent
(8)
Administration, Cutaneous
(7)
Aged
(7)
Clobetasol - Administration & Dosage
(7)
Dermatologic Agents - Adverse Effects
(7)
Psoriasis - Drug Therapy
(7)
Administration, Topical
(6)
Drug Therapy, Combination
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis

A randomized controlled pilot study of strategies to increase adherence in teenagers with acne vulgaris

Sequential Treatment with Triple Combination Cream and Intense Pulsed Light is More Efficacious than Sequential Treatment with an Inactive (Control) Cream and Intense Pulsed Light in Patients with Moderate to Severe Melasma

Safety and Tolerability of a Body Wash and Moisturizer When Applied to Infants and Toddlers with a History of Atopic Dermatitis: Results from an Open-Label Study

Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma

A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% cream

Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial

Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris

Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis

A multi-center, open-label study to evaluate the safety and efficacy of a sequential treatment regimen of clobetasol propionate 0.05% spray followed by Calcitriol 3 mg/g ointment in the management of plaque psoriasis

The impact of natural sunlight exposure on the UVB-sun protection factor (UVB-SPF) and UVA protection factor (UVA-PF) of a UVA/UVB SPF 50 sunscreen

An Open-label, Multicenter Study of the Efficacy and Safety of a Weekday/Weekend Treatment Regimen With Calcitriol Ointment 3 μg/g and Clobetasol Propionate Spray 0.05% in the Management of Plaque Psoriasis

Is switching retinoids a sound strategy for the treatment of acne vulgaris?

An Open-Label, Multicenter Study of the Efficacy and Safety of an AM/PM Treatment Regimen With Clobetasol Propionate Spray 0.05% and Calcitriol Ointment 3 μg/g in the Management of Plaque Psoriasis

The Appearance of Facial Foundation Cosmetics Applied After Metronidazole Gel 1

Successful Treatment of Moderate to Severe Melasma With Triple-Combination Cream and Glycolic Acid Peels : A Pilot Study

Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15

Triple Combination Cream and Glycolic Acid Peels for the Treatment of Moderate to Severe Melasma

Clobetasol Propionate 0.05% Spray vs Calcipotriene 0.005%, Betamethasone Dipropionate 0.064% Ointment for the Treatment of Plaque Psoriasis: Results from a Randomized Study

The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasis

The Evolving Role of Topical Treatments in Adjunctive Therapy for Moderate to Severe Plaque Psoriasis: The COBRA Trial: A large-scale community-based trial on moderate and severe psoriasis

An open-label, multicenter study of the efficacy and safety of a weekday/weekend treatment regimen with calcitriol ointment 3 microg/g and clobetasol propionate spray 0.05% in the management of plaque psoriasis

An open-label, multicenter study of the efficacy and safety of an AM/PM treatment regimen with clobetasol propionate spray 0.05% and calcitriol ointment 3 microg/g in the management of plaque psoriasis

Morphology control of metal-modified zirconium phosphate support structures for the oxygen evolution reaction

Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

Suchergebnisse filtern